Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: A 6-week, multicenter, randomized, double-blind, phase III, noninferiority clinical trial
Số trang: 9
Loại file: pdf
Dung lượng: 478.97 KB
Lượt xem: 8
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Pelubiprofen is a prodrug of 2-arylpropionic acid with relatively selective effects on cyclooxygenase-2 activity. The aim of this study was to compare the efficacy and safety profiles of pelubiprofen with those of celecoxib in patients with rheumatoid arthritis.
Nội dung trích xuất từ tài liệu:
Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: A 6-week, multicenter, randomized, double-blind, phase III, noninferiority clinical trial
Nội dung trích xuất từ tài liệu:
Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: A 6-week, multicenter, randomized, double-blind, phase III, noninferiority clinical trial
Tìm kiếm theo từ khóa liên quan:
BMC Musculoskeletal Disorders Rheumatoid arthritis Non-inferiority 2-arylpropionic acid Cyclooxygenase-2 activityTài liệu liên quan:
-
Neolignans and flavonol glycosides from the leaves of Viburnum lutescens blume
8 trang 40 0 0 -
10 trang 31 0 0
-
Predicting short stay total hip arthroplasty by use of the timed up and go-test
7 trang 31 0 0 -
6 trang 28 0 0
-
Risk factors for musculoskeletal pain amongst nurses in Estonia: A cross-sectional study
7 trang 25 0 0 -
12 trang 25 0 0
-
10 trang 22 0 0
-
10 trang 22 0 0
-
Validation of the Mayo Hip Score: Construct validity, reliability and responsiveness to change
7 trang 20 0 0 -
15 trang 20 0 0